Progress and strategy update
Verici Dx plc (AIM: VRCI), a developer of advanced clinical diagnostics for organ transplant, announces that CEO Sara Barrington and CFO David Anderson will provide a live progress and strategy update presentation via the Investor Meet Company platform on Tuesday 18 January 2022 at 3:00pm GMT. This follows the recent update announcement released on 12 January 2022.1
The presentation is open to all existing and potential shareholders. Questions can be submitted pre-event via your Investor Meet Company dashboard up until 9am the day before the meeting or at any time during the live presentation.
Investors can sign up to Investor Meet Company for free and add to meet VERICI DX PLC via:
https://www.investormeetcompany.com/verici-dx-plc/register-investor
Investors who already follow Verici Dx plc on the Investor Meet Company platform will automatically be invited.
Notes:
1 https://vericidx.com/progress-and-strategy-update/
OFFICE & LABORATORY ADDRESS:
393 Nichol Mill Lane, Suite 200
Franklin, TN 37067
REGISTERED OFFICE:
Avon House
19 Stanwell Road
Penarth
Cardiff, CF64 2EZ
CALL US AT:
Phone: +1 (833) 243-4552
Fax: +1 (629) 235-4545
